Daniel Bensen, Chief Operating Officer at Tyra Biosciences, Inc. (TYRA), sold 2,400 shares at $16.03 ($39K) on 2023-07-17, disclosed to the SEC on 2023-07-17.
Scheduled sale ($39k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.13 | 500 | $8K | 20.9% |
| 2 | $16.03 | 1,900 | $30K | 79.1% |
| Total | $16.05 avg | 2,400 | $39K | 100% |
| Filing → |
| TYRA | SELL | 2025-12-16 | $181K | — | Filing → |
| TYRA | SELL | 2025-11-19 | $4.1M | — | Filing → |
| TYRA | SELL | 2025-11-17 | $4.2M | — | Filing → |